Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells

Hepatology

Volumn 55, Issue 3, 2012, Pages 879-887

  Knight, Virginia ^a,b   Tchongue, Jorge ^a,b   Lourensz, Dinushka ^a,b   Tipping, Peter ^a   Sievert, William ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN; GELATINASE A; HYDROXYPROLINE; MESSENGER RNA; PROCOLLAGEN; PROTEINASE ACTIVATED RECEPTOR 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CHRONIC LIVER DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL;

ANIMALS; CARBON TETRACHLORIDE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEPATIC STELLATE CELLS; HUMANS; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGOPEPTIDES; RECEPTOR, PAR-2; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 84857443370     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24784     Document Type: Article

References (24)

1. Friedman S. Mechanisms of hepatic fibrosis. Gastroenterology 2008; 134: 1655-1669.
2. Riewald M, Ruf W. Orchestration of coagulation protease signaling by tissue factor. Trends Cardiovasc Med 2002; 12: 149-154.
3. Tacke F, Luedde T, Trautwein C. Inflammatory pathways in liver injury and liver homeostasis. Clin Rev Allergy Immunol 2009; 36: 4-12.
4. Anstee Q, Wright M, Goldin R, Thursz M. Parenchymal extinction: coagulation and hepatic fibrogenesis. Clin Liver Dis 2009; 13: 117-126.
5. Borensztajn K, von der Thüsen JH, Peppelenbosch MP, Spek CA. The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm. J Cell Mol Med 2010; 14: 143-153.
6. D'Andrea M, Derian C, Leturcq D, Baker S, Brunmark A, Ling P, et al. Characterization of protease-activated receptor 2 immunoreactivity in normal human tissue. J Histochem Cytochem 1998; 46: 157-164.
7. Farrell DJ, Hines JE, Walls AF, Kelly PJ, Bennett MK, Burt AD. Intrahepatic mast cells in chronic liver diseases. HEPATOLOGY 1995; 22: 1175-1181.
8. Borensztajn K, Bresser P, van der Loos C, Bot I, van den Blink B, den Bakker MA, et al. Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-Induced lung injury. Potential role in pulmonary fibrosis. Am J Pathol 2010; 177: 2753-2764.
9. Xiong J, Zhu Z, Liu J, Wang Y, Li Z. Role of protease activated receptor 2 expression in renal interstitial fibrosis model in mice. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 523-526.
10. Fiorucci S, Antonelli E, Distrutti E, Severino B, Fiorentina R, Baldoni M, et al. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation. HEPATOLOGY 2004; 39: 365-375.
11. Patella S, Phillips DJ, Tchongue J, deKretser DM, Sievert W. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 2006; 290: G137-G144.
12. Moussa L, Apostolopoulos J, Davenport P, Tchongue J, Tipping PG. Protease-activated receptor-2 augments experimental crescentic glomerulonephritis. Am J Pathol 2007; 171: 800-808.
13. Scotton C, Krupiczojc, Königshoff M, Mercer P, Lee YC, Kaminski N, et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest 2009; 119: 2550-2563.
14. Rullier A, Duplantier J, Costet P, Cubel G, Haurie V, Petibois C, et al. Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2009; 294: G226-G235.
15. Masamune A, Kikuta K, Satoh M, Suzuki N, Shimosegawa T. Protease activated receptor 2-mediated proliferation and collagen production of rat pancreatic stellate cells. J Pharmacol Exp Ther 2005; 312: 651-658.
16. Cederqvist K, Haglund C, Heikkila P, Hollenberg MD, Karikoski R, Andersson S. High expression of pulmonary proteinase-activated receptor 2 in acute and chronic lung injury in preterm infants. Pediatr Res 2005; 57: 831-836.
17. Borensztajn K, Stiekema J, Nijmeijer S, Reitsma P, Peppelenbosch M, Spek A. Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease activated receptor 2 activation. Am J Pathol 2008; 172: 309-320.
18. Gaca, MD, Zhou X, Benyon RC. Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. J Hepatol 2002; 36: 362-369.
19. Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol 1987; 138: 2611-2615.
20. Marra F, Aleffi S, Galastri S, Provenzano A. Monocytes in liver fibrosis. Semin Immunopathol 2009; 31: 345-358.
21. Rallabhandi P, Nhu QM, Toshchakov VY, Piao W, Medvedev AE, Hollenberg MD, et al. Analysis of proteinase-activated receptor 2 and TLR4 signal transduction, a novel paradigm for receptor cooperativity. J Biol Chem 2008; 283: 24314-24325.
22. Ikeda K, Wakahara T, Wang YQ, Kadoya H, Kawada N, Kaneda K. In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. HEPATOLOGY 1999; 29: 1760-1767.
23. Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007; 46: 955-975.
24. Kanke T, Kabeya M, Kubo S, Kondo S, Yasuoka K, Tagashira J, et al. Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo. Br J Pharmacol 2009; 158: 361-371.